| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-8281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3298 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-2033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-16877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3298 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-145 |
| filingDate |
2017-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2020-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2020501697-A |
| titleOfInvention |
Fluid delivery device having a control assembly and method of use thereof |
| abstract |
A method of administering an agent suitable for treating migraine or cluster headache to a patient in need thereof comprises placing the mounting surface of a fluid delivery device containing the agent in contact with at least a portion of the patient's skin. Including steps. The flow rate of the drug from the fluid delivery device is adjusted such that the drug is delivered to the patient for at least a predetermined period of time. The fluid delivery device includes a control assembly having a body part defining an axis and a plunger part slidably coupled to the body part. The plunger component is positionable between a first position where the plunger component is closest to the body component and a second position farthest from the body component. The biasing assembly is located between the body part and the plunger part. The biasing assembly is configured to apply a two-stage force profile to the plunger component. Also disclosed is a method of administering an agent to a patient such that C max , T max, and AUC are within predetermined therapeutically effective values. [Selection diagram] FIG. |
| priorityDate |
2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |